LINC01834

Across TCGA pan-cancer cohorts, LINC01834 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated LINC01834 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01834 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01834 expression acts as an unfavorable survival marker.

ACC, STAD, and THCA are the cancer types where LINC01834 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.046	0.753	<.001	72	view →
STAD	OS	Tertile	II,III,IV	0.145	0.572	.001	27	view →
THCA	OS	Tertile	II,III,IV	0.923	0.976	.001	27	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

LINC01834–ACC (DFS)

Open the ACC breakdown →